In the rapidly evolving field of drug discovery, single-cell analysis has become an invaluable tool for understanding cellular heterogeneity and molecular pathways. However, traditional single-cell ...
Nanovials are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing ...
Bruker Corporation today announced the launch of the Beacon Discovery ™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop ...
SAN DIEGO & BERLIN & DURHAM, N.C.--(BUSINESS WIRE)--Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally ...
Lightcast Discovery Ltd., a pioneering life science tools company, today announced the limited commercial release of its Envisia™ benchtop platform — a breakthrough droplet-based, single-cell ...
Researchers have developed a discovery platform to probe the function of genes involved in metabolism -- the sum of all life-sustaining chemical reactions. The investigators used the new platform, ...
McGill University researchers have identified a brain function that helps explain why childhood stress raises metabolic health risks for some women later in life. A new study found that variations in ...
A Compact Benchtop Optofluidic System with Lower Cost of Ownership for Broader Research Accessibility EMERYVILLE, Calif.--(BUSINESS WIRE)-- Bruker Corporation (BRKR) (Nasdaq: BRKR) today announced the ...
Building on Bruker’s proprietary Opto-Electrical Positioning (OEP) technology and scalable OptoSelect™ microfluidic chips, Beacon Discovery complements the floor-standing premium Beacon® platforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results